We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

221 hedge funds and large institutions have $674M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 77 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

92,654% more call options, than puts

Call options by funds: $46.4M | Put options by funds: $50K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 226 → 221 (-5)

5.47% less ownership

Funds ownership: 107.8% → 102.34% (-5.5%)

10% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 77

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

40% less capital invested

Capital invested by funds: $1.12B → $674M (-$443M)

Holders
221
Holders Change
-5
Holders Change %
-2.21%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
69
Reduced
77
Closed
44
Calls
$46.4M
Puts
$50K
Net Calls
+$46.3M
Net Calls Change
-$27.1M

Top Buyers

1
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12.8M
2
KCM
Kynam Capital Management
New Jersey
+$11M
3
SCM
Stonepine Capital Management
Oregon
+$5.12M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.23M
5
State Street
State Street
Massachusetts
+$3.64M

Top Sellers

1
BCM
Brown Capital Management
Maryland
-$16.8M
2
Man Group
Man Group
United Kingdom
-$11.2M
3
GT
Glenmede Trust
Pennsylvania
-$9.1M
4
JP Morgan Chase
JP Morgan Chase
New York
-$8.31M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GRP
201
Global Retirement Partners
California
$981 +$1.28K +238 New
BIA
202
Bell Investment Advisors
California
$890 – – –
PA
203
Parallel Advisors
California
$820 +$1.07K +199 New
Osaic Holdings
204
Osaic Holdings
Arizona
$556 -$7.28K -1,354 -91%
PS
205
Principal Securities
Iowa
$552 -$290 -54 -29%
TWD
206
True Wealth Design
Ohio
$462 +$602 +112 New
FMII
207
Farmers & Merchants Investments Inc
Nebraska
$416 – – –
CSB
208
City State Bank
Iowa
$412 – – –
RIL
209
Rothschild Investment LLC
Illinois
$412 +$349 +65 +186%
CPA
210
Capital Performance Advisors
California
$358 +$468 +87 New
CYG
211
Clean Yield Group
Vermont
$350 – – –
PWMG
212
Private Wealth Management Group
New Jersey
$338 -$2.74K -509 -86%
FFA
213
Farther Finance Advisors
California
$338 -$704 -131 -62%
HNB
214
Huntington National Bank
Ohio
$288 +$376 +70 New
AAP
215
Arax Advisory Partners
Colorado
$260 +$339 +63 New
MPWT
216
MassMutual Private Wealth & Trust
Connecticut
$181 -$151 -28 -39%
AWM
217
Abound Wealth Management
Tennessee
$141 – – –
MFG
218
Mendota Financial Group
Wisconsin
$46 +$59 +11 New
N
219
Natixis
France
$8 – – –
BCM
220
Brown Capital Management
Maryland
– -$16.8M -2,580,875 Closed
GT
221
Glenmede Trust
Pennsylvania
– -$9.1M -1,395,983 Closed
First Eagle Investment Management
222
First Eagle Investment Management
New York
– -$7.2M -1,104,225 Closed
TI
223
Trexquant Investment
Connecticut
– -$5.42M -831,416 Closed
FP
224
Foundry Partners
Minnesota
– -$1.66M -254,177 Closed
Marshall Wace
225
Marshall Wace
United Kingdom
– -$1.42M -217,218 Closed
7 8
9
10 11

IRWD Hedge Fund Activity: Q3 2024 in Review

221 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2024, worth a combined $674M — down 40% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IRWD and 39 opened new positions — a net loss of 5 holders — while 77 trimmed existing stakes and 69 added.

The largest buyer was Pacer Advisors, adding an estimated $12.8M. The largest seller was Brown Capital Management, exiting entirely with an estimated $16.8M sold.

  • 221 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2024, down from 226 in Q2 2024.
  • Funds reported $674M of Ironwood Pharmaceuticals stock for Q3 2024, down 40% quarter-over-quarter.
  • 39 funds opened new Ironwood Pharmaceuticals positions in Q3 2024 and 44 closed out, a net change of -5 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2024 was Pacer Advisors, an estimated $12.8M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2024 was Brown Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q3 2024.